Skip to main content
Log in

Convulsion during cyclosporin A therapy for nephrotic syndrome

  • CASE REPORT
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

A 10-year-old boy with nephrotic syndrome developed convulsions 6 weeks after the start of cyclosporin A (CyA) therapy. Generalized tonic-clonic convulsion occurred during relapse of nephrotic syndrome after influenza A infection. T2-weighted magnetic resonance imaging (MRI) showed high signal intensities in bilateral parieto-occipital lobes. He recovered from the convulsions and the MRI findings returned to normal early without neurological sequelae. CyA was discontinued for 1 week and then restarted. He has had no further convulsions or recurrence of nephrotic syndrome since that time. He had no evidence of high blood level of CyA, hypertension, electrolyte abnormalities, or renal or hepatic dysfunction. He was diagnosed with CyA-related reversible posterior leukoencephalopathy syndrome based on the rapid recovery of clinical symptoms and the characteristic MRI finding. Influenza A infection may have damaged the blood-brain barrier, paving the way for central nervous system toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: December 3, 1998 / Accepted: June 7, 1999

About this article

Cite this article

Motoyama, O., Shigetomi, Y., Sawai, K. et al. Convulsion during cyclosporin A therapy for nephrotic syndrome. Clin Exp Nephrol 4, 63–66 (2000). https://doi.org/10.1007/s101570050064

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s101570050064

Navigation